The Government Employees Medical Scheme (GEMS) revised its contribution increase to provide members with further financial relief. At the same time, it aims to protect the scheme’s long-term sustainability. GEMS principal officer Dr Stan Moloabi said the scheme is “acutely aware” of rising living costs and the impact on public servants and their families.
GEMS is one of South Africa’s biggest restricted medical schemes. It reports over 890,000 principal members and around 2.4 million beneficiaries, including dependants. That scale makes contribution decisions material for households, organised labour, and the wider healthcare funding market.
GEMS 2026 Contribution Increase Timeline
The announcement on 7 May 2026 follows earlier adjustments this year. GEMS previously communicated an average increase of 9.8% from 1 January 2026. Later, this was reduced to 9.5% from 1 February 2026.
The latest move lowers the weighted average increase to 7.5%. Implementation is set for 1 July 2026. This remains subject to formal approval by the Council for Medical Schemes (CMS).
GEMS said the decision followed a structured review by its Board of Trustees and engagement with government and organised labour. The Department of Public Service and Administration’s publication on the decision also notes discussions involving the Minister for Public Service and Administration, Inkosi Mzamo Buthelezi. Other stakeholders were also involved.
Why The Scheme Says Costs Keep Climbing
GEMS said healthcare costs continue to rise due to higher provider tariffs, medicine prices, medical technology costs and increased utilisation by members. Those pressures are not unique to GEMS. Moreover, they reflect broader medical inflation dynamics across the sector.
Against that backdrop, the scheme framed the lower increase as a product of improved financial performance and tighter operations. Moloabi pointed to initiatives to contain costs, strengthen claims management and improve operational efficiency. As a result, GEMS said these steps strengthened its financial position and created room to “return value” to members by allowing a lower increase.
What Employers And Providers Should Watch
For employers and unions, the key question will be whether the July adjustment translates into noticeable monthly relief across salary bands. Another question is how quickly the CMS finalises approval. For providers, the decision reinforces a familiar tension. Schemes are under pressure to protect affordability while managing utilisation and negotiating tariff growth.
GEMS also signalled that cost discipline will continue. It said it will monitor claims trends closely and strengthen interventions against fraud, waste and abuse. That focus may affect authorisation rules, network strategies and payment scrutiny across hospitals, specialists and pharmacies.
Read the Original Article (May require a subscription)